Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveBridgeBio reports improved symptoms in Phase 3 trial of rare-disease drug

Live News NEWS FLASH L impact Oct 11, 2026, 04:14 PM UTC

BridgeBio reports improved symptoms in Phase 3 trial of rare-disease drug

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

Anthropic to spend $111b on Google Cloud computing deal - WSJ L impact | NEWS | Oct 20, 2026, 07:42 PM UTC Anthropic to spend $31b on Microsoft cloud computing deal - WSJ $MSFT L impact | NEWS | Oct 20, 2026, 07:42 PM UTC Anthropic to spend up to $86b on renting Nvidia chips - WSJ $NVDA L impact | NEWS | Oct 20, 2026, 07:42 PM UTC Anthropic is on the hook to pay around $450 billion in cloud computing agreements over the next seven to ten years - WSJ L impact | NEWS | Oct 20, 2026, 07:37 PM UTC Anthropic to spend more than $600b on compute - WSJ L impact | NEWS | Oct 20, 2026, 07:32 PM UTC Anthropic S-1 Shows Red-Hot Growth, Risks and Massive Computing Costs - WSJ L impact | NEWS | Oct 20, 2026, 07:32 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.